JPWO2022012683A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022012683A5
JPWO2022012683A5 JP2023502585A JP2023502585A JPWO2022012683A5 JP WO2022012683 A5 JPWO2022012683 A5 JP WO2022012683A5 JP 2023502585 A JP2023502585 A JP 2023502585A JP 2023502585 A JP2023502585 A JP 2023502585A JP WO2022012683 A5 JPWO2022012683 A5 JP WO2022012683A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023546764A (ja
JP7829546B2 (ja
JP2023546764A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/106892 external-priority patent/WO2022012683A1/en
Publication of JP2023546764A publication Critical patent/JP2023546764A/ja
Publication of JPWO2022012683A5 publication Critical patent/JPWO2022012683A5/ja
Publication of JP2023546764A5 publication Critical patent/JP2023546764A5/ja
Application granted granted Critical
Publication of JP7829546B2 publication Critical patent/JP7829546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502585A 2020-07-16 2021-07-16 Ｃｄ１９結合分子及びその使用 Active JP7829546B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/102457 2020-07-16
CN2020102457 2020-07-16
PCT/CN2021/106892 WO2022012683A1 (en) 2020-07-16 2021-07-16 Cd19 binding molecules and uses thereof

Publications (4)

Publication Number Publication Date
JP2023546764A JP2023546764A (ja) 2023-11-08
JPWO2022012683A5 true JPWO2022012683A5 (https=) 2024-07-11
JP2023546764A5 JP2023546764A5 (https=) 2024-07-11
JP7829546B2 JP7829546B2 (ja) 2026-03-13

Family

ID=79554496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502585A Active JP7829546B2 (ja) 2020-07-16 2021-07-16 Ｃｄ１９結合分子及びその使用

Country Status (9)

Country Link
US (1) US20230192883A1 (https=)
EP (1) EP4182351A4 (https=)
JP (1) JP7829546B2 (https=)
KR (1) KR20230038706A (https=)
CN (1) CN116457464A (https=)
AU (1) AU2021309145A1 (https=)
CA (1) CA3186065A1 (https=)
IL (1) IL299867A (https=)
WO (1) WO2022012683A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12590148B2 (en) 2018-11-26 2026-03-31 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
AU2020232691B2 (en) 2019-03-05 2023-06-29 Nkarta, Inc. CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
JP7846667B2 (ja) 2020-07-16 2026-04-15 レジェンド バイオテック アイルランド リミテッド Ｃｄ２０結合分子及びその使用
WO2025029930A1 (en) 2023-07-31 2025-02-06 Legend Biotech Ireland Limited Cells overexpressing cd31 and methods of use thereof
WO2025137089A1 (en) * 2023-12-19 2025-06-26 Beam Therapeutics Inc. Cd19-binding polypeptides, compositions comprising the same, and methods for use thereof
WO2025214438A1 (zh) * 2024-04-10 2025-10-16 浙江纳米抗体技术中心有限公司 结合cd19和/或cd22的抗原结合分子及其用途
WO2026035951A2 (en) 2024-08-07 2026-02-12 Legend Biotech Ireland Limited Cells overexpressing cd43 and methods of use thereof
WO2026055226A1 (en) 2024-09-03 2026-03-12 Legend Biotech Ireland Limited Cells overexpressing b3gnt2 and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
WO2010130832A2 (en) * 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
EP3293199B1 (en) * 2016-09-08 2021-01-13 Heinrich-Heine-Universität Düsseldorf Chimeric antigen receptors
CN108276493B (zh) * 2016-12-30 2023-11-14 南京传奇生物科技有限公司 一种嵌合抗原受体及其应用
CN106939048A (zh) * 2017-03-25 2017-07-11 康众（北京）生物科技有限公司 一种CD3ε×CD19双特异性纳米抗体及其制备方法
PL3823990T3 (pl) * 2018-07-20 2026-04-20 TeneoTwo, Inc. Przeciwciała łańcucha ciężkiego wiążące się z cd19
JP2022513164A (ja) * 2018-11-30 2022-02-07 セルラリティ インク． 胎盤由来同種ｃａｒ－ｔ細胞およびその使用
CN110396128B (zh) * 2019-03-21 2022-09-06 南京东极医药科技有限公司 抗cd19纳米抗体的制备

Similar Documents

Publication Publication Date Title
JP2025028239A5 (https=)
FI3334765T3 (fi) Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi
JP2025065142A5 (https=)
TWI820041B (zh) 新型抗CD3ε抗體
JP2021087455A5 (https=)
CA3020864A1 (en) Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof
JP2022501043A5 (https=)
RU2020120853A (ru) Мультиспецифичные химерные рецепторы, содержащие домен nkg2d, и способы их применения
US20240052052A1 (en) Novel anti-cd24 antibodies
JP7503642B2 (ja) 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法
JP2021526844A5 (https=)
EP4426437A1 (en) Methods of treating cancers and enhancing efficacy of bcmaxcd3 bispecific antibodies
JPWO2020160050A5 (https=)
JPWO2022012683A5 (https=)
WO2023010100A1 (en) Novel anti-sirpa antibodies
JPWO2019245991A5 (https=)
JPWO2022012681A5 (https=)
CA3234153A1 (en) Antibodies binding to cd30 and cd3
JPWO2020113108A5 (https=)
JPWO2022012680A5 (https=)
JPWO2021226163A5 (https=)
JPWO2023056243A5 (https=)
JP7854121B2 (ja) 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法
JPWO2022127871A5 (https=)
WO2025045018A1 (en) Anti-gamma delta tcr antibodies and uses thereof